Neuronetics, Inc.
STIM
$4.48
$0.245.66%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 74.89M | 72.71M | 72.07M | 73.23M | 71.35M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 74.89M | 72.71M | 72.07M | 73.23M | 71.35M |
| Cost of Revenue | 20.13M | 15.77M | 17.36M | 17.93M | 17.74M |
| Gross Profit | 54.76M | 56.94M | 54.70M | 55.30M | 53.61M |
| SG&A Expenses | 75.96M | 73.35M | 72.52M | 71.83M | 72.74M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 108.86M | 98.33M | 98.83M | 98.83M | 100.00M |
| Operating Income | -33.97M | -25.62M | -26.76M | -25.61M | -28.65M |
| Income Before Tax | -43.73M | -36.42M | -32.47M | -27.54M | -30.19M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -43.73 | -36.42 | -32.47 | -27.54 | -30.19 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 19.00K | -- | -- | -- | -- |
| Net Income | -43.71M | -36.42M | -32.47M | -27.54M | -30.19M |
| EBIT | -33.97M | -25.62M | -26.76M | -25.61M | -28.65M |
| EBITDA | -31.98M | -23.58M | -24.75M | -23.65M | -26.74M |
| EPS Basic | -1.38 | -1.22 | -1.10 | -0.95 | -1.06 |
| Normalized Basic EPS | -0.80 | -0.63 | -0.65 | -0.62 | -0.68 |
| EPS Diluted | -1.38 | -1.22 | -1.10 | -0.95 | -1.06 |
| Normalized Diluted EPS | -0.80 | -0.63 | -0.65 | -0.62 | -0.68 |
| Average Basic Shares Outstanding | 126.46M | 118.84M | 117.45M | 115.99M | 114.55M |
| Average Diluted Shares Outstanding | 126.46M | 118.84M | 117.45M | 115.99M | 114.55M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |